Biased Signaling in Psychedelic Action.
Annu Rev Pharmacol Toxicol August 12, 2025 Peer reviewed DOI: 10.1146/annurev-pharmtox-062124-012545 via PubMed Central
Abstract
Biased Signaling in Psychedelic Action.
Related reading
- Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists. British journal of pharmacology • May 23, 2025 • via PubMed
- Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists. ACS chemical neuroscience • August 2, 2023 • via PubMed
- The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior. Pharmacological reports : PR • February 1, 2026 • via PubMed
- Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin March 4, 2026 • via OpenAlex
- The G protein biased serotonin 5-HT 2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice. bioRxiv : the preprint server for biology • June 5, 2023 • via PubMed